Last 12 months
Inside the activity.
2 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2021 Filed Mar 5, 2021 21:39 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,332 | $0.00 Strike: $40.10 | $0.00 |
DisclosureSEC source: 0001214659-21-002792 · marketforms-51772.xml · derivative · entry 3 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,332 shares Expires 2031-03-03 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:39 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 9,039.2 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002792 · marketforms-51772.xml · nonDerivative · entry 2 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,985.04 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 59,932.040 vested restricted stock units and 9,053 shares of Common Stock. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:39 UTC |
Sharpe Matthew P.Executive Vice President
|
GrantCommon Stock | 2,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002792 · marketforms-51772.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,945.84 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 3, 2022. F2 · balance_after: Represents 50,892.840 vested restricted stock units and 9,053 shares of Common Stock. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:38 UTC |
Rugenstein WadeExecutive Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 19,396 | $0.00 Strike: $40.10 | $0.00 |
DisclosureSEC source: 0001214659-21-002791 · marketforms-51771.xml · derivative · entry 2 Rugenstein Wade · CIK 0001782331 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,396 shares Expires 2031-03-03 F3 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:38 UTC |
Rugenstein WadeExecutive Vice President
|
GrantCommon Stock | 2,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002791 · marketforms-51771.xml · nonDerivative · entry 1 Rugenstein Wade · CIK 0001782331 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607.788 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 3, 2022. F2 · balance_after: Represents vested restricted stock units. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:36 UTC |
Desrochers Mark RSenior Vice President
|
GrantCommon Stock | 2,465.795 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002789 · marketforms-51769.xml · nonDerivative · entry 2 Desrochers Mark R · CIK 0001479392 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,382.795 F2 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F3 · balance_after: Represents 2,465.795 vested restricted stock units and 4,917 shares of Common Stock. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:36 UTC |
Desrochers Mark RSenior Vice President
|
GrantCommon Stock | 2,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002789 · marketforms-51769.xml · nonDerivative · entry 1 Desrochers Mark R · CIK 0001479392 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,917 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:38 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
GrantCommon Stock | 1,644.624 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002790 · marketforms-51770.xml · nonDerivative · entry 2 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,392.962 F2 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:38 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
GrantCommon Stock | 1,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002790 · marketforms-51770.xml · nonDerivative · entry 1 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,748.338 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:36 UTC |
CONKLIN BRET AEVP & CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,272 | $0.00 Strike: $40.10 | $0.00 |
DisclosureSEC source: 0001214659-21-002787 · marketforms-51767.xml · derivative · entry 4 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,272 shares Expires 2031-03-03 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:36 UTC |
CONKLIN BRET AEVP & CFO
|
GrantCommon Stock | 5,340.929 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002787 · marketforms-51767.xml · nonDerivative · entry 2 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,190.276 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 36,742.256 vested share-based restricted stock units, 9,931.556 deferred cash restricted stock units and 516.464 shares of Common Stock. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:36 UTC |
CONKLIN BRET AEVP & CFO
|
GrantCommon Stock | 2,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002787 · marketforms-51767.xml · nonDerivative · entry 1 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,849.347 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 3, 2022. F2 · balance_after: Represents 31,401.327 vested share-based restricted stock units, 9,931.556 deferred cash restricted stock units and 516.464 shares of Common Stock. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:35 UTC |
Carley Donald MGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 14,548 | $0.00 Strike: $40.10 | $0.00 |
DisclosureSEC source: 0001214659-21-002786 · marketforms-51764.xml · derivative · entry 3 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,548 shares Expires 2031-03-03 F5 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 3, 2022. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:35 UTC |
Carley Donald MGeneral Counsel
|
GrantCommon Stock | 4,519.75 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002786 · marketforms-51764.xml · nonDerivative · entry 2 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,057.058 F3 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested. F4 · balance_after: Represents 12,558.058 vested restricted stock units and 5,499 shares of Common Stock. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:35 UTC |
Carley Donald MGeneral Counsel
|
GrantCommon Stock | 1,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-002786 · marketforms-51764.xml · nonDerivative · entry 1 Carley Donald M · CIK 0001665149 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,537.308 F1 · security: The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 3, 2022. F2 · balance_after: Represents 8,038.308 vested restricted stock units and 5,499 shares of Common Stock. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 20:35 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 3,333 | $40.00 | $133,320.00 |
DisclosureSEC source: 0001214659-21-002480 · marketforms-51682.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,016.068 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020. F2 · balance_after: Represents 179,523.068 vested restricted stock units and 53,493 shares of Common Stock. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 20:58 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $38.88 | $136,080.00 |
DisclosureSEC source: 0001214659-21-002065 · marketforms-51533.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,945.84 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · balance_after: Represents 50,892.840 vested restricted stock units and 9,053 shares of Common Stock. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 19:19 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $42.15 | $147,525.00 |
DisclosureSEC source: 0001214659-21-000646 · marketforms-50969.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,189.84 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · balance_after: Represents 50,892.840 vested restricted stock units and 4,297 shares of Common Stock. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 19:18 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 3,334 | $42.15 | $140,528.10 |
DisclosureSEC source: 0001214659-21-000645 · marketforms-50968.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,349.068 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020. F2 · balance_after: Represents 179,523.068 vested restricted stock units and 56,826 shares of Common Stock. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 17:24 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 550 | $41.66 | $22,912.34 |
DisclosureSEC source: 0001214659-21-000185 · marketforms-50874.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,890.443 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.32 to $42.36. F3 · balance_after: Represents 11,158.443 vested restricted stock units and 6,732 shares of Common Stock. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 20:06 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $42.85 | $149,975.00 |
DisclosureSEC source: 0001214659-20-010500 · marketforms-50660.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,329.198 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · balance_after: Represents 50,532.198 vested restricted stock units and 7,797 shares of Common Stock. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 20:04 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 3,334 | $42.85 | $142,861.90 |
DisclosureSEC source: 0001214659-20-010499 · marketforms-50659.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,411.023 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020. F2 · balance_after: Represents 178,251.023 vested restricted stock units and 60,160 shares of Common Stock. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 00:02 UTC |
Stricker RobertDirector
|
SaleCommon Stock | 2,500 | $40.00 | $100,000.00 |
DisclosureSEC source: 0001214659-20-009744 · marketforms-50128.xml · nonDerivative · entry 2 Stricker Robert · CIK 0001478287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,252.21 F2 · balance_after: Represents 12,267.657 vested share-based restricted stock units, 11,017.553 deferred cash restricted stock units and 5,967 shares of Common Stock. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 16:26 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $40.09 | $140,315.00 |
DisclosureSEC source: 0001214659-20-009681 · marketforms-50140.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,829.198 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · balance_after: Represents 50,532.198 vested restricted stock units and 11,297 shares of Common Stock. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 16:22 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 3,334 | $40.09 | $133,660.06 |
DisclosureSEC source: 0001214659-20-009680 · marketforms-50141.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,745.023 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020. F2 · balance_after: Represents 178,251.023 vested restricted stock units and 63,494 shares of Common Stock. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:02 UTC |
Stricker RobertDirector
|
SaleCommon Stock | 2,500 | $40.00 | $100,000.00 |
DisclosureSEC source: 0001214659-20-009744 · marketforms-50128.xml · nonDerivative · entry 1 Stricker Robert · CIK 0001478287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,752.21 F1 · balance_after: Represents 12,267.657 vested share-based restricted stock units, 11,017.553 deferred cash restricted stock units and 8,467 shares of Common Stock. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 20:27 UTC |
ZURAITIS MARITADirector · President & CEO
|
SaleCommon Stock | 3,334 | $40.00 | $133,360.00 |
DisclosureSEC source: 0001214659-20-009390 · marketforms-50121.xml · nonDerivative · entry 1 ZURAITIS MARITA · CIK 0001198960 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,079.023 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020. F2 · balance_after: Represents 178,251.023 vested restricted stock units and 66,828 shares of Common Stock. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 17:25 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 3,500 | $34.05 | $119,175.00 |
DisclosureSEC source: 0001214659-20-008713 · marketforms-49863.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,329.198 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · balance_after: Represents 50,532.198 vested restricted stock units and 14,797 shares of Common Stock. Read SEC document |
| October 12, 2020 Filed Oct 13, 2020 20:42 UTC |
McClure Beverley J.Director
|
SaleCommon Stock | 550 | $34.07 | $18,738.50 |
DisclosureSEC source: 0001214659-20-008572 · marketforms-49857.xml · nonDerivative · entry 1 McClure Beverley J. · CIK 0001577358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,427.379 F1 · kind: The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2020. F2 · balance_after: Represents 11,079.379 vested restricted stock units and 4,348 shares of Common Stock. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 17:55 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
SaleCommon Stock | 1,301 | $34.15 | $44,422.78 |
DisclosureSEC source: 0001214659-20-008202 · marketforms-49785.xml · nonDerivative · entry 1 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,481.466 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.14 to $34.21. F2 · balance_after: Represents 16,481.466 vested restricted stock units. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 21:39 UTC |
JOHNSON KIMBERLY ASVP & Controller
|
SaleCommon Stock | 1,428.636 | $34.04 | $48,623.63 |
DisclosureSEC source: 0001214659-20-008090 · marketforms-49755.xml · nonDerivative · entry 1 JOHNSON KIMBERLY A · CIK 0001708307 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,782.466 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.96 to $34.15. F2 · balance_after: Represents 16,481.466 vested restricted stock units and 1,301 shares of Common Stock. Read SEC document |
| September 18, 2020 Filed Sep 22, 2020 16:01 UTC |
CONKLIN BRET AEVP & CFO
|
SaleCommon Stock | 2,010 | $34.90 | $70,142.57 |
DisclosureSEC source: 0001214659-20-008025 · marketforms-49720.xml · nonDerivative · entry 1 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,140.109 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.89 to $34.90. F2 · balance_after: Represents 30,901.109 vested share-based restricted stock units, 9,773.402 deferred cash restricted stock units and 465.598 shares of Common Stock held directly. Read SEC document |
| September 08, 2020 Filed Sep 9, 2020 01:06 UTC |
CONKLIN BRET AEVP & CFO
|
SaleCommon Stock | 4,046 | $38.06 | $154,010.59 |
DisclosureSEC source: 0001214659-20-007730 · marketforms-49657.xml · nonDerivative · entry 2 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,149.109 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.06 to $38.12. F4 · balance_after: Represents 30,901.109 vested share-based restricted stock units, 9,773.402 deferred cash restricted stock units and 2,474.598 shares of Common Stock held directly. Read SEC document |
| September 03, 2020 Filed Sep 9, 2020 01:06 UTC |
CONKLIN BRET AEVP & CFO
|
SaleCommon Stock | 4,031 | $38.35 | $154,583.21 |
DisclosureSEC source: 0001214659-20-007730 · marketforms-49657.xml · nonDerivative · entry 1 CONKLIN BRET A · CIK 0001247242 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,195.109 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.33 to $38.38. F2 · balance_after: Represents 30,901.109 vested share-based restricted stock units, 9,773.402 deferred cash restricted stock units and 6,520.598 shares of Common Stock held directly. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,901 | $0.00 Strike: $31.01 | $0.00 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · derivative · entry 12 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,901 shares Expires 2026-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,209 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · derivative · entry 11 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,209 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 11,515 | $38.74 | $446,070.37 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · nonDerivative · entry 7 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,635.303 F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.58 to $39.05. F9 · balance_after: Represents 50,082.303 vested restricted stock units and 26,553 shares of Common Stock. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 10,901 | $31.01 | $338,040.01 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · nonDerivative · entry 6 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,150.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · balance_after: Represents 50,082.303 vested restricted stock units and 38,068 shares of Common Stock. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 3,209 | $32.35 | $103,811.15 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · nonDerivative · entry 5 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,249.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · balance_after: Represents 50,082.303 vested restricted stock units and 27,167 shares of Common Stock. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,995 | $0.00 Strike: $31.01 | $0.00 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · derivative · entry 10 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,901 Underlying: Common Stock · 1,995 shares Expires 2026-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,081 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · derivative · entry 9 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,209 Underlying: Common Stock · 9,081 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,113 | $0.00 Strike: $28.88 | $0.00 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · derivative · entry 8 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,113 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 10,418 | $38.94 | $405,631.08 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · nonDerivative · entry 4 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,040.303 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.81 to $39.11. F5 · balance_after: Represents 50,082.303 vested restricted stock units and 23,958 shares of Common Stock. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 1,995 | $31.01 | $61,864.95 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · nonDerivative · entry 3 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,458.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Represents 50,082.303 vested restricted stock units and 34,376 shares of Common Stock. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 9,081 | $32.35 | $293,770.35 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · nonDerivative · entry 2 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,463.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Represents 50,082.303 vested restricted stock units and 32,381 shares of Common Stock. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:10 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionCommon Stock | 1,113 | $28.88 | $32,143.44 |
DisclosureSEC source: 0001214659-20-007401 · marketforms-49503.xml · nonDerivative · entry 1 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,382.303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Represents 50,082.303 vested restricted stock units and 23,300 shares of Common Stock. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,464 | $0.00 Strike: $31.01 | $0.00 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · derivative · entry 12 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,896 Underlying: Common Stock · 7,464 shares Expires 2026-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,162 | $0.00 Strike: $32.35 | $0.00 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · derivative · entry 11 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,290 Underlying: Common Stock · 1,162 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,682 | $0.00 Strike: $28.88 | $0.00 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · derivative · entry 10 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113 Underlying: Common Stock · 1,682 shares Expires 2024-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 19:03 UTC |
Sharpe Matthew P.Executive Vice President
|
SaleCommon Stock | 8,626 | $39.20 | $338,140.06 |
DisclosureSEC source: 0001214659-20-007305 · marketforms-49483.xml · nonDerivative · entry 7 Sharpe Matthew P. · CIK 0001543801 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,269.303 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.05 to $39.53. F4 · balance_after: Represents 50,082.303 vested restricted stock units and 22,187 shares of Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.